GA treatment inhibited BLM-induced upregulation of α-SMA and also reduced BLM-induced upregulation of TGF-β1 and phosphorylation of Smad2/3, suggesting that GA may mitigate BLM-induced pulmonary fibrosis by inhibiting TGF-β signaling pathway. This evidence concerns the gene ACTA1 and pulmonary fibrosis.